{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:46Z","timestamp":1782280006958,"version":"3.54.5"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Simple post-ERCP hyperamylasemia is a common biochemical finding after therapeutic endoscopic retrograde cholangiopancreatography (ERCP), but pediatric data integrating procedural characteristics with stool microbiome features remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed an exploratory single-center observational pilot study of 24 successful therapeutic ERCP procedures in children younger than 18 years with pancreatobiliary obstructive disorders between January 2024 and December 2025. The primary endpoint was simple post-ERCP hyperamylasemia, defined as serum amylase &amp;gt;3 times the upper limit of normal within 24\u2005h after ERCP without new or worsening abdominal pain. Baseline clinical variables, predefined stool microbiome features derived from pre-ERCP metagenomic data (Shannon diversity,\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      abundance, and\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      abundance), and intraprocedural variables were compared between groups. Exploratory signal prioritization was used only to identify candidate associations for future validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hyperamylasemia occurred in 8\/24 procedures (33.3%). Compared with non- hyperamylasemia group, the affected children had higher baseline gamma-glutamyl transferase and C-reactive protein, longer procedure time, more difficult cannulation, more inadvertent pancreatic duct cannulation, more pancreatic contrast injection, and more rescue precut access. Stool microbiome features in the hyperamylasemia group included lower Shannon diversity, higher\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      abundance, and lower\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      abundance. Procedure time and Shannon diversity emerged as the most interpretable combined signals, but all model estimates should be viewed cautiously because of the small event count.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this pilot dataset, simple post-ERCP hyperamylasemia clustered with technically demanding procedures and a low-diversity,\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      -enriched stool microbiome profile. These findings are hypothesis-generating and require prospective multicenter validation before they can inform pediatric ERCP surveillance or risk-stratification research.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1851821","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:51:03Z","timestamp":1782276663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and stool microbiome correlates of simple post-ERCP hyperamylasemia in children undergoing therapeutic ERCP for pancreatobiliary obstructive disorders: an exploratory pilot study"],"prefix":"10.3389","volume":"14","author":[{"given":"Xueqi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Capital Center for Children\u2019s Health, Capital Medical University, Capital Institute of Pediatrics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Capital Center for Children\u2019s Health, Capital Medical University, Capital Institute of Pediatrics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Capital Center for Children\u2019s Health, Capital Medical University, Capital Institute of Pediatrics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihuan","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Capital Center for Children\u2019s Health, Capital Medical University, Capital Institute of Pediatrics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Diao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Capital Center for Children\u2019s Health, Capital Medical University, Capital Institute of Pediatrics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MPG.0000000000003001","article-title":"Medical management of chronic pancreatitis in children: a position paper by the north American society for pediatric gastroenterology, hepatology, and nutrition pancreas committee","volume":"72","author":"Freeman","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/MPG.0000000000003439","article-title":"The role of surgical management in chronic pancreatitis in children: a position paper from the north American society for pediatric gastroenterology, hepatology, and nutrition pancreas committee","volume":"74","author":"Nathan","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jpeds.2014.11.019","article-title":"Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden","volume":"166","author":"Schwarzenberg","year":"2015","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamapediatrics.2015.4955","article-title":"Risk factors associated with pediatric acute recurrent and chronic pancreatitis: lessons from INSPPIRE","volume":"170","author":"Kumar","year":"2016","journal-title":"JAMA Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","article-title":"Definitions of pediatric pancreatitis and survey of present clinical practices","volume":"55","author":"Morinville","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MPG.0000000000001715","article-title":"Management of acute pancreatitis in the pediatric population: a clinical report from the NASPGHAN pancreas committee","volume":"66","author":"Abu-El-Haija","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/MPG.0000000000002664","article-title":"The roles of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the evaluation and treatment of chronic pancreatitis in children","volume":"70","author":"Liu","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1177\/2050640616687868","article-title":"ERCP In infants, children and adolescents is feasible and safe: results from a tertiary care center","volume":"5","author":"Felux","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/MPG.0b013e31829e0bb6","article-title":"Endoscopic retrograde cholangiopancreatography in the pediatric population is safe and efficacious","volume":"57","author":"Enestvedt","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpeds.2016.08.046","article-title":"Complications of endoscopic retrograde cholangiopancreatography in pediatric patients: a systematic literature review and meta-analysis","volume":"179","author":"Usatin","year":"2016","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s12887-023-04392-5","article-title":"Indications, success, and adverse event rates of pediatric endoscopic retrograde cholangiopancreatography (ERCP): a systematic review and meta-analysis","volume":"23","author":"Hosseini","year":"2023","journal-title":"BMC Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/MPG.0000000000003612","article-title":"Technical outcomes in pediatric endoscopic retrograde cholangiopancreatography: data from an international collaborative","volume":"75","author":"Troendle","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","article-title":"Incidence rates of post-ERCP complications: a systematic survey of prospective studies","volume":"102","author":"Andriulli","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1067\/mge.2001.117550","article-title":"Risk factors for post-ERCP pancreatitis: a prospective, multicenter study","volume":"54","author":"Freeman","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1572-0241.2006.00380.x","article-title":"Risk factors for post-ERCP pancreatitis: a prospective multicenter study","volume":"101","author":"Cheng","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1055\/s-0034-1377875","article-title":"Prophylaxis of post-ERCP pancreatitis: european society of gastrointestinal endoscopy (ESGE) guideline - updated June 2014","volume":"46","author":"Dumonceau","year":"2014","journal-title":"Endoscopy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-1075-4080","article-title":"ERCP-related adverse events: european society of gastrointestinal endoscopy (ESGE) guideline","volume":"52","author":"Dumonceau","year":"2020","journal-title":"Endoscopy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5114\/wiitm.2020.94545","article-title":"A grey zone of hyperamylasemia following endoscopic retrograde cholangiopancreatography: follow-up and differential diagnosis from acute pancreatitis","volume":"16","author":"Cakir","year":"2021","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/medicina58091261","article-title":"Post-ERCP pancreatitis: prevention, Diagnosis and Management","volume":"58","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.gie.2009.10.027","article-title":"A lexicon for endoscopic adverse events: report of an ASGE workshop","volume":"71","author":"Cotton","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.gie.2022.10.005","article-title":"American Society for gastrointestinal endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations","volume":"97","author":"Buxbaum","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00150","DOI":"10.14309\/ctg.0000000000000150","article-title":"Disordered gut Microbiota in children who have chronic pancreatitis and different functional gene mutations","volume":"11","author":"Wang","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/gutjnl-2023-330987","article-title":"Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis","volume":"73","author":"Ammer-Herrmenau","year":"2024","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41522-024-00499-4","article-title":"Integrative metagenomic and metabolomic analyses reveal the potential of gut microbiota to exacerbate acute pancreatitis","volume":"10","author":"Liu","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.dld.2023.10.011","article-title":"Acute pancreatitis is associated with gut dysbiosis in children","volume":"56","author":"Dike","year":"2024","journal-title":"Dig Liver Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1002\/deo2.236","article-title":"The safety and efficacy of ringer\u2019s solution loading with rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: the RESOLUTION-PEP study","volume":"3","author":"Hattori","year":"2023","journal-title":"DEN Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/SLE.0000000000001202","article-title":"Effects of somatostatin and indomethacin mono or combination therapy on high-risk hyperamylasemia and post-pancreatitis endoscopic retrograde cholangiopancreatography patients: a randomized study","volume":"33","author":"Wu","year":"2023","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jfma.2020.10.034","article-title":"Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized clinical trials","volume":"120","author":"Chiu","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e35174","DOI":"10.1097\/MD.0000000000035174","article-title":"Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis based on prospective, randomized, and controlled trials","volume":"102","author":"Xie","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2127456","DOI":"10.1080\/19490976.2022.2127456","article-title":"Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses","volume":"14","author":"Li","year":"2022","journal-title":"Gut Microbes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6662000","DOI":"10.1155\/2021\/6662000","article-title":"Primary needle-knife sphincterotomy for biliary access in patients at high risk of post-endoscopic retrograde cholangiopancreatography pancreatitis","volume":"2021","author":"Park","year":"2021","journal-title":"Gastroenterol Res Pract"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.12659\/MSM.913314","article-title":"Risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis: evidence from 1786 cases","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.1038\/s41598-024-60312-2","article-title":"GGT1 Is a SNP eQTL gene involved in STAT3 activation and associated with the development of post-ERCP pancreatitis","volume":"14","author":"Furukawa","year":"2024","journal-title":"Sci Rep"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1851821\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:51:18Z","timestamp":1782276678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1851821\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":35,"alternative-id":["10.3389\/fped.2026.1851821"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1851821","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1851821"}}